CHARANPREET KAUR: Open Payments
NPI 1225758717 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 12 payments from 8 companies in 2025. Trend: 2023 $92 · 2024 $158 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $162 |
| Corcept Therapeutics | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ABBVIE INC. | 1 | $26 |
| Grifols USA, LLC | 1 | $23 |
| Insulet Corporation | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, Korlym, AIRSUPRA, UBRELVY, Prolastin-C Liquid, Omnipod, NUZYRA, OTEZLA.
Industry payments across NC — which companies pay providers there.
